Fundraising FoxAgent Capital — 2019 Investments
4 investments dated 2019 · listed companies and verified rows first · show all
Pyxis Oncology develops antibody-drug conjugates and immunotherapies targeting difficult-to-treat cancers to improve patient outcomes.
BiotechDigital HealthHealthtechMedical DevicesBoston, US
Thomas Civik(Interim Chief Executive Officer, Director)
BoardDavid Steinberg(Executive Officer, Director)inChristoph Westphal(Director)Jak Knowles(Director)John Flavin(Director)
Board seatGeeta Vemuri· per SEC Form D
Co-investorsLifeSci Venture PartnersLongwood FundPfizer Venture InvestmentsRA CapitalTrans-Pacific Technology FundRTW Investments L.P.
BiotechWarrington, US
Mary B. Templeton(Executive Officer)Craig E. Fraser(Executive Officer, Director)Lawrence A. Weinstein(Executive Officer)Kathryn Cole(Executive Officer)John Tattory(Executive Officer)George Cox(Executive Officer)in
Board seatBruce Peacock· per SEC Form D · $26.4M raise · filed Dec 2019
Co-investorsPanacea Venture
Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.
BiotechHealthtechPhiladelphia, US
Karyn O'Neil(Executive Officer, Director)Susan Dillon(Founder)inMark V. Laurenzi(Executive Officer)
BoardElizabeth Anderson(Director)
Board seatBruce Peacock· per SEC Form D · $5M raise · filed Jan 2020
Co-investorsAvego BioScience CapitalHealthCapBiotechnology Value FundCowen Healthcare InvestmentsJohnson & Johnson Innovation – JJDCNorthpond Ventures
Ocular Therapeutix focuses on drug development and treatment for retinal diseases, with an emphasis on wet age-related macular degeneration and expanding into diabetic retinopathy conditions.
BiotechDigital HealthHealthtechMedical DevicesBedford, US
Amarpreet Sawhney(Director)Kevin Hanley(Executive Officer)Michael Goldstein(Executive Officer)inDaniel Bollag(Executive Officer)Antony Mattessich(Executive Officer, Director)inDonald Notman(Executive Officer)in
Board seatBruce Peacock· per SEC Form D · $37.5M raise · filed Mar 2019
Co-investorsAscension VenturesSofinnova VenturesSV Health InvestorsTop Corner Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.